FDA Raps US WorldMeds for Unsupported Treatment Claims

Washington Drug Letter
A A
US WorldMeds, a specialty drugmaker, has been issued a warning letter from the FDA, noting false claims and omitted risk information for the company’s drug Revonto.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00